CPTAC is a comprehensive and coordinated effort
to accelerate the understanding of the molecular basis of cancer through the application of robust, quantitative, proteomic technologies and workflows.
CPTAC is a multicenter and interdisciplinary project coordinated by National Cancer Institute at NIH.
The IIMO has been awarded 4-years contract from NIH funded by federal funds from government of the United States.
1. Identify and characterize the protein inventory from tumor and normal tissue biospecimens
2. Integrate genomic and proteomic data from analysis of common cancer biospecimens
3. Develop assays against proteins prioritized in the discovery stage as potential biomarker candidates
4. Perform testing of verification assays in relevant cohorts of biospecimens
Participating oncology hospitals and oncology leaders: